Chidamide Plus Etoposide and Cisplatin/Carboplatin as First-line Treatment for Extrapulmonary Neuroendocrine Carcinoma

NCT05076786 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Neuroendocrine Tumors
Neuroendocrine Carcinoma

Interventions

DRUG: Chidamide
DRUG: Etoposide + Cisplatin/Carboplatin

Sponsor

Peking Union Medical College Hospital

Collaborators

[object Object]
[object Object]